KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stereotaxis (STXS) Other Operating Expenses (2016 - 2025)

Stereotaxis (STXS) has disclosed Other Operating Expenses for 16 consecutive years, with $2.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses fell 6.92% to $2.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $11.8 million, a 3.85% decrease, with the full-year FY2024 number at $12.4 million, changed 0.03% from a year prior.
  • Other Operating Expenses was $2.9 million for Q3 2025 at Stereotaxis, up from $2.8 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $3.3 million in Q2 2023 to a low of $2.8 million in Q2 2025.
  • A 5-year average of $3.0 million and a median of $3.0 million in 2021 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: increased 19.79% in 2021, then dropped 15.87% in 2025.
  • Stereotaxis' Other Operating Expenses stood at $3.0 million in 2021, then dropped by 1.91% to $3.0 million in 2022, then dropped by 6.59% to $2.8 million in 2023, then rose by 4.48% to $2.9 million in 2024, then increased by 0.62% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for STXS's Other Operating Expenses are $2.9 million (Q3 2025), $2.8 million (Q2 2025), and $3.1 million (Q1 2025).